Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Jul 29, 2020
Covid-19 Narratives Driving the Markets

Covid-19 Narratives Driving the Markets

Our vocabulary has expanded this year. How many people knew the term “novel coronavirus” before January 2020? We’re familiar with SARS and H1N1. Everyone’s contracted a form of the flu at some point. Parents have herded their children inside to avoid mosquito born EEE. Those harrowing narratives have been common in recent years. This is different.

Covid-19, the newest novel coronavirus, is a world-wide pandemic. As of today, it has infected fifteen million people and killed over six hundred thousand. This virus has affected out thoughts, behaviors, and at times crippled national economies. The carnage seems to have settled for now, but what happens if we get a second wave, as health experts predict?

Obviously, the markets have been affected by all this. As a trader, it’s difficult to wrap your head around because technical analysis alone cannot accurately predict market behavior during conditions like we are currently experiencing. You need to rely on fundamental analysis. Watch the news. The following narratives are likely to affect the markets.

Narrative #1: Huge Crowds at BLM Protests and Trump Rallies in the US

Let’s start with the United States. Divided into fifty states with individual governing authorities controlling lock downs, it’s difficult to predict if, when, or where a second wave might arise. Some states have been cautious in their re-opening strategy. Others, like Florida and Texas, sprung everyone from their homes far too early. Covid-19 numbers are already rising there. 

Add in massive crowds protesting for the Black Lives Matter movement and election rallies for President Trump. The country, particularly in the larger cities, is now a petri dish for another outbreak. When and where will that happen and how will it affect the market? Here are a few possible scenarios you should look at before making any trade decisions: 

  1. Texas is in trouble. After a knock-out blow delivered by the Saudi/Russia price cuts earlier this year, another coronavirus shutdown could spell the end for many of the smaller oil companies working the Permian Basin and East Texas Oil Field. Look for mid-size firms on the brink and bet on the downslope. 

  2. Florida is also on the verge of another shutdown. Carnival (CCL), Royal Caribbean (RCL), Spirit (SAVE), Marriott (VAC), and Hertz (HTZ) are based there. Most of these stocks have already dropped to historic lows. Expect that decline to continue.

  3. California, despite a surge in new cases, is doing fine. Home to Apple, Tesla, Netflix, and eBay, the technology capital of the US has actually thrived throughout the Covid-19 crisis. Look for big upsides on some of these firms if the country shuts down again. 

There’s no predicting how the large crowds that gathered during the height of the virus will impact the health care system in the United States, so stay away from health stocks. Moderna did close a deal with the Pentagon this week. Get your money now. They’ve never delivered an approved product before. It’s questionable whether they’ll be able to do it this time. 

Narrative #2: Constitutional Voting and Victory Day in Russia

With 67% of voters showing up for constitutional voting on July 1st and massive crowds turning out for the rescheduled Victory Day on June 24th, Russia may be at risk for a second wave of Covid-19 cases in a few weeks. Keep that in mind if you’re trading on the Moscow Exchange. Returns are likely to start declining soon, so don’t bet on a continuing upslope.

The best move in the Russia space right now may be in the forex market. The ruble is showing a downtrend at the moment, so traders are selling and looking for put options. The Stochastic indicator suggests a 58% chance of an uptrend happening soon. The ruble has exited the oversold zone, which usually results in a price increase. Be prepared to buy on the upslope.

Expect Yandex (YNDX) to end its brief bull run later this week. It’s been sitting in the overbought zone for ten days and the bubble is expected to break. Look to sell or grab some put options to leverage your portfolio. Bloomberg predicted this week that the Russian economy is expected to shrink 5.4% this year, so downtrends are likely to happen soon. 

Narrative #3: Singapore GDP Plunges 41.2%

The Asian markets took yet another hit this week when Singapore sunk into recession with a 41.2% drop in gross domestic product. The export-dependent nation is just the latest casualty in a region devastated by Covid-19 outbreaks and their corresponding shutdowns. Singapore had eased its lockdown on June 1st. It’s now facing an outbreak of Dengue Fever.

Singapore is not alone. Japan is showing a 20% decrease in GDP. China seems to have weathered the virus and is starting to show economic growth again, making the Yuan a good play for traders. Check out WisdomTree Chinese Yuan Strategy ETF (CYB). The Aroon indicator shows it in the uptrend. The momentum indicator gives it a 27% chance to stay there. 

One scenario to watch in Singapore is the human clinical trials authorized for a new vaccine developed by Arcturus Pharmaceuticals in San Diego (ARCT). Arcturus is listed on Tickeron as a solid buy with a momentum indicator that shows a 73% chance of a continuous uptrend. Be prepared to buy and hold, though. This is definitely not a day trade.

Narrative #4: Israel Re-Implements Shin Bet Covid-19 Tracking System 

This is an interesting scenario with a hidden investment opportunity. Israel has long been known for having some of the best security technology in the world. They are now using that tech to track and monitor their own people for Covid-19 outbreaks. The national domestic security agency, Shin Bet, is in charge of the program.

Yuval Diskin, a former head of Shin Bet and one of the minds behind their security system, cofounded a cybersecurity startup in 2018. The company is called Opora. They recently did a round of seed funding ($7 million) with Jerusalem Venture Partners, the venture fund that launched IPOs for CyberArk, QLIK Technologies, and Cogent Communications. 

Watch for an IPO from Opora. The media attention that Shin Bet tech is receiving right now should drive the price up quickly. In the meantime, CyberArk (CYBR) is showing as a strong buy with a 70% uptrend on the momentum indicator. Cogent Communications (CCOI) is also on an uptrend with a 72% chance of staying there. Israeli tech companies are looking good.   

 Narrative #5: Australia Sets a “Hard Boundary” around Melbourne

With new cases spiking in Melbourne, Australia made the decision this week to set up a hard boundary around the city. The lockdown covers the city and nearby region of Mitchell Shire. Residents are essentially locked in. Only people needing medical attention and essential workers are allowed to leave their homes. Victoria Police have roadblocks set up.

The response seems extreme, but the number of new cases continues to rise, definitive signs of a second outbreak. The benchmark S&P/ASX 200 index showed a 1.3% decline yesterday, falling 81 points to 6075.1. Health company Mesoblast (MESO) was one of the biggest losers of the day, falling 6.8% to $3.45 per share. The Australian dollar has stayed strong. 

Is there a trading opportunity here? Pay attention to the signals. The biggest gainer on the ASX yesterday was Resolute Mining, which surged 12.9%. The stock is only selling for $1.40 a share, so there may be a decent call option there, but it’s the industry they are in that you’ll want to monitor closely. Resolute Mining explores, develops, and operates gold mines.

In times of uncertainty, gold goes up. Barrick Gold (GOLD) closed Wednesday at a five-year high of $28.52. Tickeron Signals recommends it as a Strong Buy. The momentum indicator shows the stock on an upslope with a 77% chance of staying there. It’s a good buy and hold, an opportunity for call options, and has enough intraday movement for day traders.     

Tips for Riding out the Second Wave

Tech stocks were the most resilient during the first wave. There’s no reason to believe we won’t see the same scenario during the second wave. Amazon will continue to uptrend. Netflix is volatile and needs a content infusion, something that’s unlikely to happen if film production studios remain hindered by lockdowns. Keep an eye on that situation in California.

Play the forex market. National currencies are showing a lot of movement right now. Crypto is an area of opportunity also. Consumer confidence around the globe has wavered when it comes to their own governments, a natural reaction to personal adversity. Cryptocurrencies are expected to surge in the upcoming months if we see a second wave.

Use common sense. What we are about to go through is unprecedented on a global scale. As the summer wains, Covid-19 will surge. Traders should look forward to new opportunities. There’s a presidential election coming up in the United States in November. That will rock the markets, regardless of results.  

P.S For crypto-enthusiasts, join the Investor Club: "Nakamoto Club"

Related Ticker: BNBX

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of botanical deoxyribonucleic acid based security and authentication solutions

Industry InvestmentManagers

Profile
Details
Industry
Information Technology Services
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.